Comparing medical treatments for Crohn's disease

Author： Renna Sara Orlando Ambrogio Cottone Mario

ISSN： 2042-6305

Source： Journal of Comparative Effectiveness Research, Vol.2, Iss.2, 2013-03, pp. : 135-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Magnetic resonance imaging‐quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 343-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunotherapy of Crohn's disease

By Montfrans C. Van Camoglio L. Deventer S. J. H. Van

Mediators of Inflammation, Vol. 7, Iss. 3, 1998-06 ,pp. : 149-152

Informa Healthcare

Access to resources Recommend Favorite

Autophagy and Crohn's Disease

Journal of Innate Immunity, Vol. 5, Iss. 5, 2013-01 ,pp. : 434-443

Karger

Access to resources Recommend Favorite

Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity‐matched analysis

NEPHROLOGY, Vol. 20, Iss. S4, 2015-12 ,pp. : 22-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for ulcerative colitis and Crohn's disease

PRESCRIBER, Vol. 26, Iss. 10, 2015-05 ,pp. : 22-24

John Wiley & Sons Inc

Access to resources Recommend Favorite